| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |